None listed
Conditions
Interventions
Medical Device : Insert a silicone covered metal stent or plastic stent into a urethral occlusion patient caused by a malignant tumor.
Sponsors
S&G Biotech
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients under the age of 20 and under 80 who understood the purpose of the clinical trial and signed a written consent form upon voluntary consent. 2) Patients with expected life expectancy of more than 3 months 3) Patients who have not previously undergone metal ureter stent insertion 4) Patients diagnosed with urethral stenosis due to malignant tumors
Exclusion criteria
Exclusion criteria: 1) If diagnosed with urinary epithelial cancer 2) In case of bladder erosion of a malignant tumor 3) In case of past history of Kidney transmission 4) Patients with bladder function including reduction of bladder flow rate 5) Patients with ECOG performance status greater than 3 6) A woman who is likely to become pregnant, a woman who breast-feeds a baby. 7) If the researcher believes that the research is not suitable for carrying out the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary patency rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Technical success rate;Final patency rate;Primary patency rate;Adverse event;discomfort caused by stent;Patient survival rate for 6 months after treatment | — |
Countries
Korea, Republic of
Contacts
Public ContactDeok Hyun Han
Samsung Medical Center
Outcome results
None listed